NCT06196606View on ClinicalTrials.gov

Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

December 12, 2024

Study Completion Date

December 12, 2024

Conditions
Brain Stem InfarctionsDysphagia, OropharyngealDysphagia, Esophageal
Interventions
DRUG

Botulinum toxin type A for injection

Botulinum toxin was injected into the upper esophageal sphincter of each patient

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Zhengzhou University

OTHER